TY - JOUR
T1 - Incidence and predictors of postdischarge nausea and vomiting in a 7-day population
AU - Odom-Forren, Jan
AU - Jalota, Leena
AU - Moser, Debra K.
AU - Lennie, Terry A.
AU - Hall, Lynne A.
AU - Holtman, Joseph
AU - Hooper, Vallire
AU - Apfel, Christian C.
PY - 2013/11
Y1 - 2013/11
N2 - Study Objective 1) To quantify the incidence and severity of postdischarge nausea and vomiting (PDNV) for 7 days in adults undergoing outpatient surgeries with general anesthesia; 2) to evaluate whether a risk model previously developed for the first two postoperative days may be used to predict the patient's risk of PDNV for 7 days; and 3) to verify whether the same risk factors are applicable in the 3 to 7 day period. Design Prospective study. Setting Two university-affiliated centers. Patients 248 adult (> 18 years) surgical outpatients undergoing ambulatory surgical procedures with general anesthesia between 2007 and 2008. Measurements The incidence and severity of PDNV and a simplified risk score for PDNV was assessed prospectively from discharge up to 7 postoperative days. Main Results The overall incidence of nausea was 56.9% and of emesis was 19.4%. The incidence of PDNV was highest on the day of surgery (DOS), with PDNV of 44.8% and decreasing over time to 6.0% on day 7. Using the simplified risk score for PDNV the area under the receiver operating characteristic (ROC) curve was 0.766 (0.707, 0.825). A previous history of postoperative nausea and vomiting (PONV; OR 3.51, CI 1.70 - 7.27), operating room time (odds ratio [OR] 2.19, 95% CI 1.34 - 3.60), use of ondansetron in the Postanesthesia Care Unit (PACU; OR 6.39, CI 1.65-24.79), and pain during days 3-7 (OR 1.67, CI 1.30 - 2.14) were the strongest predictors of PDNV on days 3-7. Conclusions PDNV affects a significant number of patients after ambulatory surgery, and our simplified PDNV score may be applied to a 7-day population. Pain appears to be a factor in late PDNV. It is possible that the presence of PDNV during days 3-7 has different origins from the PDNV that resolved over the first 48 hours.
AB - Study Objective 1) To quantify the incidence and severity of postdischarge nausea and vomiting (PDNV) for 7 days in adults undergoing outpatient surgeries with general anesthesia; 2) to evaluate whether a risk model previously developed for the first two postoperative days may be used to predict the patient's risk of PDNV for 7 days; and 3) to verify whether the same risk factors are applicable in the 3 to 7 day period. Design Prospective study. Setting Two university-affiliated centers. Patients 248 adult (> 18 years) surgical outpatients undergoing ambulatory surgical procedures with general anesthesia between 2007 and 2008. Measurements The incidence and severity of PDNV and a simplified risk score for PDNV was assessed prospectively from discharge up to 7 postoperative days. Main Results The overall incidence of nausea was 56.9% and of emesis was 19.4%. The incidence of PDNV was highest on the day of surgery (DOS), with PDNV of 44.8% and decreasing over time to 6.0% on day 7. Using the simplified risk score for PDNV the area under the receiver operating characteristic (ROC) curve was 0.766 (0.707, 0.825). A previous history of postoperative nausea and vomiting (PONV; OR 3.51, CI 1.70 - 7.27), operating room time (odds ratio [OR] 2.19, 95% CI 1.34 - 3.60), use of ondansetron in the Postanesthesia Care Unit (PACU; OR 6.39, CI 1.65-24.79), and pain during days 3-7 (OR 1.67, CI 1.30 - 2.14) were the strongest predictors of PDNV on days 3-7. Conclusions PDNV affects a significant number of patients after ambulatory surgery, and our simplified PDNV score may be applied to a 7-day population. Pain appears to be a factor in late PDNV. It is possible that the presence of PDNV during days 3-7 has different origins from the PDNV that resolved over the first 48 hours.
KW - Ambulatory surgery
KW - Emesis control
KW - Ondansetron
KW - Outpatient anesthesia
KW - Postdischarge nausea and vomiting
UR - http://www.scopus.com/inward/record.url?scp=84889565615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84889565615&partnerID=8YFLogxK
U2 - 10.1016/j.jclinane.2013.05.008
DO - 10.1016/j.jclinane.2013.05.008
M3 - Article
C2 - 23988801
AN - SCOPUS:84889565615
SN - 0952-8180
VL - 25
SP - 551
EP - 559
JO - Journal of Clinical Anesthesia
JF - Journal of Clinical Anesthesia
IS - 7
ER -